SMS Pharmaceuticals informs about updates

22 Mar 2025 Evaluate

SMS Pharmaceuticals has informed, the United States Food and Drug Administration (USFDA) has conducted an inspection of the Company’s Active Pharmaceutical Ingredient (API) manufacturing facility located at Bachupally, Hyderabad, Telangana, it has the enclosed Company statement titled ‘Successful completion of USFDA inspection at Hyderabad facility’. The above information will also be made available on the website of the Company at www.smspharma.com.

The above information is a part of company’s filings submitted to BSE.


SMS Pharmaceuticals Share Price

337.40 0.00 (0.00%)
14-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1700.55
Dr. Reddys Lab 1186.45
Cipla 1434.60
Zydus Lifesciences 884.00
Lupin 2195.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×